About
Dr. Prerna Bhargava is a principal scientist at Cyclarity Therapeutics, a biotech company developing therapies for atherosclerosis and other chronic diseases of aging. Cyclarity says she earned a B.A. in Biotechnology from Amity University and M.S./Ph.D. degrees in Food Science & Technology from Texas A&M University. She is also listed as an author on Cyclarity research regarding removal of oxidized cholesterol to reverse foam-cell pathology in atherosclerosis.
Areas of interest
biotechcardiovascular diseaseatherosclerosislongevityaging-related diseaseoxidized cholesteroltranslational science